- Home
- BBIO vs AXS Comparison
BBIO vs AXS Comparison
Compare BBIO & AXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BBIO
- AXS
- Stock Information
- Founded
- BBIO 2015
- AXS 2001
- Country
- BBIO United States
- AXS Bermuda
- Employees
- BBIO N/A
- AXS N/A
- Industry
- BBIO Biotechnology: Pharmaceutical Preparations
- AXS Property-Casualty Insurers
- Sector
- BBIO Health Care
- AXS Finance
- Exchange
- BBIO Nasdaq
- AXS Nasdaq
- Market Cap
- BBIO 8.8B
- AXS 8.2B
- IPO Year
- BBIO 2019
- AXS N/A
- Fundamental
- Price
- BBIO $47.27
- AXS $93.83
- Analyst Decision
- BBIO Strong Buy
- AXS Strong Buy
- Analyst Count
- BBIO 16
- AXS 9
- Target Price
- BBIO $61.50
- AXS $108.25
- AVG Volume (30 Days)
- BBIO 2.2M
- AXS 680.8K
- Earning Date
- BBIO 08-05-2025
- AXS 07-29-2025
- Dividend Yield
- BBIO N/A
- AXS 1.88%
- EPS Growth
- BBIO N/A
- AXS 43.49
- EPS
- BBIO N/A
- AXS 10.40
- Revenue
- BBIO $127,415,000.00
- AXS $6,237,556,000.00
- Revenue This Year
- BBIO $106.33
- AXS $2.66
- Revenue Next Year
- BBIO $54.30
- AXS $9.92
- P/E Ratio
- BBIO N/A
- AXS $9.02
- Revenue Growth
- BBIO N/A
- AXS 7.72
- 52 Week Low
- BBIO $21.72
- AXS $70.16
- 52 Week High
- BBIO $48.68
- AXS $107.19
- Technical
- Relative Strength Index (RSI)
- BBIO 64.57
- AXS 37.30
- Support Level
- BBIO $45.11
- AXS $95.75
- Resistance Level
- BBIO $47.11
- AXS $97.77
- Average True Range (ATR)
- BBIO 1.40
- AXS 1.90
- MACD
- BBIO -0.26
- AXS -0.16
- Stochastic Oscillator
- BBIO 60.53
- AXS 13.90
About BBIO BridgeBio Pharma Inc.
BridgeBio Pharma is a biotechnology company focused on discovering, developing, testing, and delivering transformative treatments for patients with genetic diseases. The company has four programs in its late-stage pipeline focusing on Mendelian disorders, oncology, and gene therapy. One of its key programs, Attruby (acoramidis) , is an orally administered small molecule designed to stabilize tetrameric transthyretin for the treatment of transthyretin amyloid cardiomyopathy.
About AXS Axis Capital Holdings Limited
Axis Capital Holdings Ltd is a specialty underwriter and provider of insurance and reinsurance solutions with operations in Bermuda, the United States ("U.S."), Europe, Singapore, and Canada. The company manages its portfolio holistically, aiming to construct an optimum consolidated portfolio of funded and unfunded risks. The company's segment consists of AXIS Insurance and AXIS Reinsurance. The company generates the majority of its revenue from the Insurance segment. Geographically, the company generates the majority of its revenue from the United States.